Vital falls on discontinuation of ELAD system

Vital Therapies Inc. (NASDAQ:VTL) lost $5.85 (93%) to $0.45 on Wednesday after the company said it will discontinue development of

Read the full 209 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE